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ABSTRACT 
International Journal of Exercise Science 12(2): 355-365, 2019. This study examined the effects of 
Assault™ pre-workout supplementation on peak power output (PP), mean power output (MP), and percent 
decline in power output (% decline) during repeated, Wingate anaerobic tests. Thirteen healthy, physically active 
participants (7 male, 6 female) completed the randomized, double-blind, placebo-controlled crossover design 
with two conditions, supplement and placebo. The participants visited the laboratory for a total of three visits, 2-7 
days apart. During visit 1, the participants completed a 4-minute familiarization warm-up on the Monark cycle 
ergometer and performed one baseline, 30-second Wingate cycle ergometry test. During visits 2 and 3, the 
participants consumed either the pre-workout supplement or placebo flavored maltodextrin (randomized by a 
third party) and waited 20 minutes before beginning the test protocol. Each participant then completed a 4-
minute warm-up on the Monark cycle ergometer followed by four, 30-second Wingate tests, with a 5-minute rest 
between each Wingate. There were no significant two-way condition x Wingate trial interactions for PP (F=0.713, 
p=0.566), MP (F=0.669, p-value=0.590), or % decline (F=0.398 p=0.540). There was a significant main effect for the 
Wingate trial for both PP (F=10.632, p=0.002) and MP (F=11.781, p =0.001), but there was no main effect for the 
Wingate trial for % decline. There were no main effects for condition for any of the variables. The pre-workout 
supplement examined in this study did not elicit ergogenic effects on anaerobic power output (PP or MP) or the 
maintenance (% decline) during multiple Wingate tests. 
 




Pre-workout supplementation has become very popular in recreational and competitive 
athletes. Athletes ingest pre-workout supplements in an attempt to enhance focus, strength, 
and power, as well as delay fatigue (24). There are many pre-workout supplements on the 
market, containing several combinations of active ingredients, but caffeine is the primary 
active ingredient in most pre-workout supplements. The ingestion of caffeine-containing pre-
workout supplements has been shown to increase performance measures when taken 20 
minutes prior to a workout (30). Caffeine is suggested to promote strength and power 
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performance by increasing calcium release from the sarcoplasmic reticulum leading to 
increased muscle fiber contractility (26, 30). Caffeine has also been shown to delay the 
perceptions of fatigue by acting as an adenosine receptor antagonist (15). Pre-workout 
supplements also commonly contain amino acids, beta-alanine, creatine, citrulline-malate, 
arginine, and B vitamins (B-6, B-12).  These additional active ingredients are often combined 
with caffeine to produce a synergistic effect on anaerobic performance. There is, however, 
limited research on ergogenic effects of acute supplementation of caffeine in combination with 
these other active ingredients on anaerobic performance markers, such as repeated, high-
intensity cycle ergometry trials. 
 
The combination of ingredients such as caffeine, creatine, and amino acids in pre-workout 
supplements has been associated with delayed fatigue and enhanced performance during 
high-intensity anaerobic exercise (29). Pre-workout supplements containing multiple 
ingredients such as branched-chain amino acids (BCAAs), aspartic acid, and B vitamins may 
augment the effects of caffeine (5, 6, 18, 31, 34).  Branched-chain amino acids, such as leucine, 
have been shown to enhance cognitive function (34), increase protein synthesis, and decrease 
protein degradation leading to increased muscle mass (6). Aspartic acid may improve 
muscular performance by lowering the level of ammonia in the blood (4), while B vitamins, in 
particular B-6 and B-12, have displayed an important role in metabolic pathways involved in 
exercise and DNA synthesis, respectively (36). It is currently unknown, however, how the 
combination of these ingredients may augment the effects of caffeine during short-term, high 
intensity anaerobic exercise. 
 
The effectiveness of caffeine-containing pre-workout supplements for the enhancement of 
anaerobic performance remains unclear. Pre-workout supplementation has been shown to 
increase the total training volume (5, 21) as well as peak and mean power performance during 
a resistance training protocol (21). In addition, pre-workout supplementation resulted in 
increased leg press strength, perceived energy, alertness, focus, and reaction time (30). In 
contrast, pre-workout supplementation prior to a single Wingate anaerobic test was reported 
to have no significant ergogenic effects on anaerobic power or performance (10,16). Similarly, 
caffeine supplementation alone had no effect on anaerobic power or capacity from four 
Wingate anaerobic tests (22). Thus, there are data supporting (5, 21) an ergogenic effect of 
caffeine containing pre-workout supplements on anaerobic and strength parameters, but the 
effectiveness of various combinations of ingredients on anaerobic power and capacity from a 
Wingate test is less clear. No previous studies, however, have examined the effects of the 
combination of ingredients contained in the AssaultTM pre-workout supplement on anaerobic 
performance during repeated Wingate anaerobic tests. Therefore, the purpose of this study 
was to examine the effects of Assault™ pre-workout supplement containing caffeine, BCAAs, 
creatine, beta-alanine, arginine, vitamin B-6, and vitamin B-12 (Assault™, MusclePharm, Inc., 
Denver, CO, USA) on peak power output (PP), mean power output (MP), and percent decline 
in power output (% decline) during repeated Wingate anaerobic tests. We hypothesized the 
pre-workout supplement would result in an increased PP and MP, but no change or a lower % 
decline for repeated Wingate tests, compared to a placebo. 
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Fourteen healthy, college-aged students, with experience in high-intensity interval training 
were recruited for this study. One participant dropped out due to scheduling conflicts. Thus, 
the analyses included data for thirteen participants. The sample size is based on previous 
research average values of anaerobic peak power (36) using a medium-to-large effect size of 
0.5-0.8, an alpha criterion of 0.05, and a power level of 0.8. The participants consisted of 7 
males (25±4 years; 180.1±7.2 cm; 82.2±10.9kg), and 6 females (24±2 years; 163.3±14.0cm; 
64.6±6.7kg). Participants were excluded if they consumed more than 200 mg of caffeine (the 
equivalent caffeine content of 2 cups of coffee) on a regular basis, were pregnant, or had any 
allergies to the ingredients listed on the supplement label.  All participants were between the 
ages of 18-35, involved in strength training 3-5 times a week for at least one year, and were free 
from any musculoskeletal or neuromuscular injuries. The investigation was approved by the 
University of Kentucky Institutional Review Board for the protection of human testing and all 




This study was a randomized, double-blind, placebo-controlled crossover design with two 
conditions, supplement and placebo. The participants visited the Exercise Physiology 
laboratory for a total of three visits, with each visit scheduled between 2-7 days apart. 
Participants were instructed to: 1) refrain from eating 2 hours prior to testing; 2) refrain from 
exercise 12 hours prior to testing; 3) maintain their normal exercise habits and avoid any 
unaccustomed exercise bouts during their enrollment in the study; and 4) refrain from caffeine 
24 hours prior to testing. During visit 1, the participants provided informed consent, 
completed pre-exercise testing health questionnaires and personal information forms, and 
performed one baseline 30-second Wingate cycle test. After the Wingate test, the participants 
were provided a 24-hour food log to complete prior to visits 2 and 3. During visits 2 and 3, the 
participants consumed either the pre-workout supplement or placebo (randomized by a third 
party) and waited 20 minutes before beginning the test. Each participant then completed a 4-
minute warm-up on the Monark cycle ergometer followed by four 30-second Wingate tests 
with a 5-minute rest between each Wingate. 
 
Baseline Measurements: During the first visit, the body weight, heart rate, and blood pressure 
were measured, followed by a baseline Wingate test on a Monark Cycle Ergometer (Monark, 
model 894E). Prior to the test, the seat height was adjusted so that the participants’ legs were 
near full extension at the bottom of the pedal revolution. Toe cages were used to maintain 
pedal contact throughout the test. A warm-up was then performed, which consisted of 4-
minutes of cycling against 0 kg resistance, with two 5-second sprint intervals at the end of the 
2nd and 3rd minutes of the warm-up. The sprints were preformed using 7.5% of the 
participant’s body weight as resistance. A 1-mintute passive rest followed the warm-up. The 
Wingate test began with unloaded cycling where the pedaling cadence was increased as high 
as possible. The resistance (7.5% of the participant’s body weight) was automatically applied 
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when the cadence exceeded 110 rev⋅min-1 and the participants were instructed to maintain the 
cadence as high as possible for 30-seconds. The PP was measured as the highest 5-second 
average power and the MP was measured as the average power during the 30-second test (3). 
The minimum power was measured as the lowest 5-second power and was use to calculate the 
percent decline in power output (%decline) using the following equation (3): (peak power – 
minimum power/ peak power) x 100. 
 
Food log: The participants were instructed to record all food and beverages consumed 24-
hours prior to the experimental testing sessions (visits 2 and 3). The participants were asked to 
consume a similar diet prior to visits 2 and 3. The total energy and macronutrient intake (kcals) 
were quantified (www.supertracker.usda.gov) for further analysis to determine if there were 
any differences between visits 2 and 3.  
 
Table 1. AssaultTM Pre-workout supplement ingredients 
Ingredients Amount per serving 
Calories 10 
Total Carbohydrates 2 g 
Sugars 2 g 
Vitamin C 500 mg 
Vitamin E 200 IU 
Niacin 25 mg 
Vitamin B6 15 mg 
Vitamin B12 90 mcg 
Calcium 171 mg 
Sodium 50 mg 
Potassium 40 mg 
 
ATP Amplifier Blend 
Carnosyn Patented Beta Alanine (2,000 mg), L-Tyrosine, L-Aspartic Acid, Red Beet 
Extract High in Nitrates, (DMG) Dimethylglycine HCI 
3,500 mg 
 
Cellular Transport & Insulin Activator 
Dextrose, L-Glycine, Ribose, Cinnulin PF (Cinnamomum Burmannii) Bark Extract 
2,952 mg 
Athlete Performance Blend 
Creatine Nitrate, L-Arginine Nitrate,  
BCAA Nitrate 3:1:2 Ratio (L-Leucine, L-Valine, L-Isoleucine) 
2,000 mg 
Energy and Neuro Igniter 
Choline Bitartrate, Glucuronolactone, PureEnergy Matrix (Caffeine Anhydrous, 
Pterostilbene), Huperzine A 
1,750 mg 
Hydration System 
Taurine, Coconut Water Powder ,L-Glutamine 
1,200 mg 
 
Experimental Trials: Visits 2 and 3 were identical, other than the beverage that was consumed. 
Upon entering the lab, resting blood pressure and heart rate were measured and a 24-hour 
food log was collected from each participant. Next, participants consumed either a pre-
workout supplement (Table 1) or placebo beverage (randomized by a third party). Participants 
were given the supplement per label instruction, which resulted in a caffeine dose of 4.2 ± 0.69 
mg·kg-1. The placebo was flavored maltodextrin. The participants waited 20 minutes before 
performing the same 4-minute warm-up as the baseline trials. Following the warm-up, the 
participants rested for 1 minute. Next, the participants began the first of four, 30-second 
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Wingate tests with 5-minute rests in between. The Wingate tests followed the same procedures 
as the baseline trial. During the 5-minute rest, the participants were instructed to stay on the 
bike for the first minute and get back on the bike for the last minute to help reduce instances of 
nausea or fainting due to high intensity interval exercise. The other 3 minutes they were free to 
rest on or off the bike at their preference and drink water ad libitum. After completing the 
fourth Wingate tests, the participants were instructed to complete a 5 minute cool down at 
their own pace against 0 kg of resistance. 
 
Statistical Analysis 
The reliability of the Wingate test was assessed with intraclass correlation coefficient (ICC) and 
standard error of the measurement (SEM) for the baseline trial and 1st Wingate of the placebo 
condition. The peak power, mean power, and % decline values for each test were examined 
using separate, two-way (2 conditions (SUP and PL) x 4 Wingate trials) repeated measures 
ANOVAs. Follow up analyses included one-way repeated measures ANOVAs and paired 
samples t-test. In addition, paired samples t-tests were used to determine if there were 
differences in total and macronutrient energy intake (kcals) between visit 2 and visit 3. An 
alpha level of p<0.05 was considered statistically significant for all comparisons. All statistical 





The ICC values (SEM) for the peak power, mean power, and % decline were R=0.981 (38.4 W), 
R=0.980 (23.4 W), and R=0.893 (3.1 W), respectively. There was no significant two-way condition x 
Wingate trial interaction (F=0.148, p=0.928) and no main effect for condition (F=0.160, p=0.697) for 
peak power (Table 2). There was, however, a main effect (F=10.632, p=0.002) for the Wingate trial 
for peak power. The follow-up pairwise comparisons (collapsed across condition) indicated the 
peak power from trial 1 (909.3±81.3) was significantly greater than trial 2 (826.7±73.6), 3 
(743.5±57.80) and 4 (720.3±56.8). In addition, trial 2 mean power was greater than 3 and 4, but 3 
and 4 were not different (Figure 2).   
 
Table 2. Mean±SD results for four Wingate Trials within each condition, placebo (PL) and supplement (SUP), for 
peak power (PP), mean power (MP), and percent decline (%decline). Main effects for the within trial findings are 
presented in text.  
 PP MP % Decline 
 PL SUP PL SUP PL SUP 
Trial 1 904.4±280.9 914.2±308.7 603.9±168.4 614.0±174.4 57.1±8.8 55.8±8.5 
Trial 2 825.2±264.6 828.2±269.5 540.6±144.3 546.9±149.0 58.5±12.5 58.8±10.6 
Trial 3 746.5±207.2 740.5±218.2 500.6±110.3 494.6±125.2 61.1±13.7 59.1±11.8 
Trial 4 714.1±197.0 726.5±218.7 485.0±117.1 491.7±129.7 60.8±11.8 61.0±11.3 
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Figure 2. Peak power comparisons between conditions (Placebo and Supplement) for each Wingate trial. A: 
Displays no difference (no interaction effect) in anaerobic peak power for condition across all Wingate trails. B: 
Displays the mean comparisons for peak power for each Wingate trial (main effect for trial). *Lower than Trial 1 
p<0.05, #Lower than Trial 2 p<0.05 
 
There was no significant two-way condition x Wingate trial interaction (F=0.669, p-value=0.590) 
and no main effect for condition (F=0.678, p-value=0.426) for mean power. There was, however, a 
main effect (F=11.781, p =0.001) for the Wingate trial for mean power (Table 2). The follow-up 
pairwise comparisons (collapsed across condition) indicated the mean power from trial 1 
(609.0±47.4) was significantly greater than trial 2 (543.7±40.5), 3 (497.6±32.4) and 4 (488.4±33.9). In 
addition, trial 2 mean power was greater than 3 and 4, but 3 and 4 were not different (Figure 3).   
 
 
Figure 3. Mean power comparisons between conditions (Placebo and Supplement) for each Wingate trial. A: 
Displays no differences (no interaction effect) in anaerobic mean power for condition across all Wingate trials. B: 
Displays the mean comparisons for mean power for each Wingate trial (main effect for trial). *Lower than Trial 1 
p<0.05, #Lower than Trial 2 p<0.05 
 
There was no significant two-way condition x Wingate trial interaction (F=0.713, p=0.566) and no 
main effect for condition (F=0.398 p=0.540) or Wingate trial (F=1.791, p=0.212) for %decline (Table 
2; Figure 4).  
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Dietary food intake comparing visit 2 and 3 resulted in no significant difference in total kCals 




This study examined the effects of the commercially available pre-workout supplement 
AssaultTM on anaerobic power (MP and PP) and maintenance of power (% decline) using 
repeated 30 second Wingate tests. The results of the current study indicated supplementation 
with the pre-workout AssaultTM had no effect on MP, PP, or %decline. Currently, there is 
conflicting evidence regarding the effectiveness of pre-workout and/or caffeine 
supplementation to improve short-duration, high intensity anaerobic power output (9, 10, 13, 
17, 19, 21, 22, 23, 27, 35, 36). For example, previous studies showed no effect of ~1-2mg·kg-1 of 
caffeine supplementation alone on anaerobic power from a cycle ergometry sprint test in 
untrained, moderately active males and females (17) or on anaerobic power during a 25-s 
treadmill sprint test in untrained, recreationally active males (23). Furthermore, a caffeine dose 
of ~6mg·kg-1 was reported to have no effect on the anaerobic power output from repeated 
Wingate tests in untrained, moderately active males (22). In contrast, multi-ingredient pre-
workout supplementation, containing a relative does of 3.6 mg·kg-1 caffeine resulted in 
increased peak and mean anaerobic cycling power output during a single 20-s maximal effort 
test in trained males (27) and caffeine supplementation (5 mg·kg-1) alone improved Wingate 
peak power in trained male athletes (35). Thus, there is conflicting evidence regarding the 
effectiveness of caffeine and caffeine containing supplements to improve anaerobic 
performance. In contrast to previous evidence (27, 35) indicating an ergogenic effect of caffeine 
containing pre-workout supplementation and caffeine supplementation alone, the current 
findings supported those of others (17, 22, 23) and indicated no changes in anaerobic 
performance parameters after supplementation.  
 
It has been suggested that caffeine may improve anaerobic performance through several 
mechanisms including, increased motor unit firing, calcium ion mobilization from the 
sarcoplasmic reticulum, and increased nitric oxide (NO) concentration in skeletal muscle (27, 
36). These effects, however, may be dependent upon the relative caffeine dosage, subject 
training level, and muscle fiber type characteristics (17, 22, 23). Specifically, it has been 






























Figure 4. Percent decline comparisons between 
conditions (Placebo and Supplement) for each 
Wingate trial. There were no significant differences 
between the supplement or placebo for percent 
decline. 
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strength measurements in trained athletes (20). Studies have found highly trained athletes 
demonstrated an increase in anaerobic performance when consuming 4-6mg·kg-1 doses of 
caffeine (19, 35, 36), whereas untrained or non-specifically trained (i.e., not competitive 
cyclists) individuals demonstrated no improvement in anaerobic performance after similar 
caffeine doses (11, 13, 22). It is possible the lack of ergogenic effect of the pre-workout 
examined in this study is due to the low relative caffeine dosage (4.2 ± 0.69mg·kg-1; range = 
3.1-5.6 mg·kg-1) for physically active, but non-specifically trained participants (i.e., not 
competitive cyclists) (17, 22, 23). Previous studies (1, 28, 33) have also suggested the muscle 
fiber type contributions during exercise may be important determinates in the effectiveness of 
caffeine supplementation. High intensity anaerobic exercise such as Wingate cycle tests, rely 
heavily on anaerobic energy production through the phosphocreatine (PCr) and glycolytic 
pathways, which are more developed in fast-twitch glycolytic fibers (FG) (22). Caffeine acts in 
the central nervous system as an adenosine receptor antagonist (1) and may delay the onset of 
fatigue during exercise (14). Adenosine receptors are found in greater concentrations in slow 
oxidative than FG fiber types (1). Therefore, caffeine may not be as effective for improving 
high intensity cycle ergometry performance, compared with longer duration, aerobic based 
exercise, due to the reliance on anaerobic energy systems and FG fibers. 
 
The primary active ingredient in this pre-workout supplement was caffeine (30). There were, 
however, a number of other ingredients (e.g., red beet extract, dimethylglycine HCL, amino 
acids, L-tyrosine, leucine, and huperzine) that have been reported to have acute effects on 
exercise performance. For example, red beet extract has been shown to improve vascular 
control and increase skeletal muscle blood flow during exercise, therefore improving 
intramuscular pH and resynthesizing creatine phosphate (PCr) (16). There is evidence that 
dimethylglycine HCL enhances mitochondrial efficiency through vasodilation and increased 
blood flow to skeletal muscles (27). Previous studies, however, have not demonstrated 
ergogenic effects on anaerobic power output for red beet extract (8) or dimethylglycine HCL 
(2) supplementation alone. Other active ingredients such as amino acids, L-tyrosine, leucine, 
and huperzine A are known to improve cognitive function and slow the onset of fatigue in 
anaerobic exercise (12, 25, 37). It is believed that these ingredients act synergistically to 
enhance performance in anaerobic strength and power output (5). The results of this study, 
however, showed no significant difference between the supplement and placebo conditions in 
% decline (power maintenance) after consecutive Wingate trials. 
 
The pre-workout supplement examined in this study also contained ingredients that have 
potential effects on anaerobic energy metabolism after long-term dosing strategies (>4 weeks). 
For example, beta-alanine and creatine are active ingredients in the pre-workout supplement 
that independently elicit positive long-term effects on high intensity anaerobic power (27). 
Beta-alanine has been shown to increase strength and power due to increased carnosine levels 
and intramuscular buffering capacity after ~4 weeks of supplementation (32). The 
recommended dose of beta-alanine to elicit increased carnosine levels is 3-6 g·day-1 for 2 to 4 
weeks (31). Supplementation with creatine results in increased phosphocreatine stores for 
high-intensity activities after 1 to 4 week dosing strategies (7, 32). The recommended dose for 
creatine to elicit effects is 5 g·day-1 for 30 days or 20 g·day-1 for 5-7 days (7). In this study the 
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pre-workout beta-alanine and creatine dose was 2g and <2g respectively, which may not be 
great enough to increase the buffering capacity and PCr stores even if taken for at least 4 
weeks.  Future research should look at the long-term effects of this pre-workout supplement 
on anaerobic cycle ergometer performance.  
 
In conclusion, the pre-workout supplement examined in this study did not elicit ergogenic 
effects on anaerobic power (MP and PP) or power maintenance (%decline) following multiple 
Wingate tests. Further testing is warranted to determine if this pre-workout supplement will 
produce benefits in highly trained anaerobic athletes at relative doses of approximately 
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